JP Morgan Healthcare Conference - Day 1 Analysis: China and Merck

While unable to attend the JP Morgan Healthcare Conference in person, we leveraged the Amenity Viewer platform to keep tabs on the company presentation transcripts, apply our text analytics on the sentiment, and look for meaningful comments on two key themes that we have been monitoring:

1. China macro

2. Merck margin pressures after our “Deception”analysis signaled risk on the Q3 earnings call

We will continue to monitor presentations over the next couple of days to draw more insights. 

Please note: This in no way represents investment advice. All transcript text provided by S&P Global Market Intelligence.

JP Morgan Healthcare Conference: China Bulls Intact, Merck Acknowledges Challenges

China commentary remains bullish, in contrast to macro headlines and Apple

We used the Query Insights feature to identify only the meaningful comments relating to China and tariffs, rather than having to parse through more than 100 results that would come through a simple Ctrl-F on a browser window.  

  • Varian Medical Systems:

"China, despite some of the saber rattling in the newspapers and trade issues, we continue to see very strong market in China."

  • Illumina:

"I would say Q4 largely played out as we expected. And from a demand standpoint in China, which I think is the more important indicator, we don’t see an impact tariff-wise. It’s really been more of accelerating some orders from Q4 into Q3 and Q2."

Merck downticks vs Q3, more openly discusses headwinds

In our December 20 post, we highlighted risk to Merck’s margin outlook through the lens of our Deceptive Language analysis.  At the JP Morgan Conference, we got a clearer look into headwinds validating that risk.  While conference presentations typically skew positive due to the softball nature of the Q&A, Merck led off with a cautionary note, resulting in an Amenity Score of the transcript of 27, down from 49 on its Q3 earnings call.

  • Merck:

"I think ’19 is a very exciting year.  We’ve got these growth drivers, including oncology. I think we need to acknowledge, though, at the same time there’s some challenges,okay.  I mean, obviously, pricing is a challenge not just for Merck but across the industry.  And again, it underscores why being an innovating company is so important.  We’re going to face more headwinds as it relates to ForEx."

"There will be challenges with respect to the more mature and the LOE part of our portfolio with SIMPONI in Europe, for example, having to deal with generic HUMIRA."

"Within the United States, JANUVIA facing additional problems with respect to the doughnut hole calculation."

Join the Amenity Viewer Beta Program today to analyze earnings call transcriptions and enable you to spot outliers, identify critical insights, and understand key drivers.

Transcript text provided by S&P Global Market Intelligence.

Copyright ©2019. All rights reserved.

March 15, 2019

Sentiment Analysis: Tax Refunds OK, But Retail Pressures Remain

The latest IRS weekly tax return data give us the opportunity to track and compare earnings sentiment related to this year's tax refunds. This week shows refunds continue to stabilize which means they aren't the crushing headwind for Specialty Retail, so what is? Our analysis uncovers the real headwinds.
March 13, 2019

Smartsheet Earnings Preview: The Secret's Out for Our 2019 Top Pick

In December we used our text analytics platform to highlight Smartsheet (SMAR) as our top pick for 2019. Smartsheet has not disappointed, so we revisit our pick and review their latest earnings sentiment to determine if Smartsheet can close out the year atop the Technology sector.
March 8, 2019

Sentiment Analysis: Tax Refunds Stabilize, Retailers Cautious

The latest IRS weekly tax return data give us the opportunity to track and compare earnings sentiment related to this year's tax refunds. Our text analytics platform shows continued caution from retailers regarding refunds, but how much of that is truly refund related?
March 5, 2019

Earnings Preview: Q1 2019 Strengths & Weaknesses

With the majority of companies reporting Q1 earnings next month, we use our text analytics platform to uncover areas of strength and weakness for investors to explore based on the latest management commentary from this quarter's earnings calls.
Previous
Next

Stay Informed: Join Our Newsletter

Keep up to date with our analyses and how we're making changes.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
We respect your privacy. We will use your email to keep you informed about Amenity Analytics.